<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12887-019-1709-y</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12887</journal-id><journal-title-group><journal-title>BMC Pediatrics</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Pediatr</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2431</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12887-019-1709-y</article-id><article-id pub-id-type="manuscript">1709</article-id><article-id pub-id-type="doi">10.1186/s12887-019-1709-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Infection</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4985-048X</contrib-id><name><surname>Ballot</surname><given-names>Daynia E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs128870191709y_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Bandini</surname><given-names>Rosella</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Nana</surname><given-names>Trusha</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Bosman</surname><given-names>Noma</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Thomas</surname><given-names>Teena</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Davies</surname><given-names>Victor A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Cooper</surname><given-names>Peter A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Mer</surname><given-names>Mervyn</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Lipman</surname><given-names>Jeffrey</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0364 9292</institution-id><institution-id institution-id-type="GRID">grid.414707.1</institution-id><institution content-type="org-name">Neonatal Unit, Department of Paediatrics and Child Health, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital</institution></institution-wrap><addr-line content-type="city">Johannesburg</addr-line><country country="ZA">South Africa</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0364 9292</institution-id><institution-id institution-id-type="GRID">grid.414707.1</institution-id><institution content-type="org-division">Infection control</institution><institution content-type="org-name">Charlotte Maxeke Johannesburg Academic Hospital</institution></institution-wrap><addr-line content-type="postcode">2196</addr-line><addr-line content-type="city">Johannesburg</addr-line><country country="ZA">South Africa</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution content-type="org-name">Critical Care Infection Collaboration</institution></institution-wrap><addr-line content-type="city">Witwatersrand</addr-line><country country="ZA">South Africa</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution content-type="org-division">Department of Clinical Microbiology and Infectious Diseases</institution><institution content-type="org-name">School of Pathology of the National Health Laboratory Services and University of Witwatersrand</institution></institution-wrap><addr-line content-type="city">Witwatersrand</addr-line><country country="ZA">South Africa</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 1135</institution-id><institution-id institution-id-type="GRID">grid.11951.3d</institution-id><institution content-type="org-division">Department of Critical Care</institution><institution content-type="org-name">University of the Witwatersrand</institution></institution-wrap><addr-line content-type="city">Witwatersrand</addr-line><country country="ZA">South Africa</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution content-type="org-name">The University of Queensland</institution></institution-wrap><addr-line content-type="city">Brisbane</addr-line><country country="AU">Australia</country></aff></contrib-group><author-notes><corresp id="IDs128870191709y_cor1"><label>a</label><email>daynia.ballot@wits.ac.za</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>7</day><month>9</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="320">1</issue><elocation-id>320</elocation-id><history><date date-type="registration"><day>3</day><month>9</month><year>2019</year></date><date date-type="received"><day>25</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>3</day><month>9</month><year>2019</year></date><date date-type="online"><day>7</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Multi-drug resistant organisms are an increasingly important cause of neonatal sepsis.</p></sec><sec id="ASec2"><title>Aim</title><p id="Par2">This study aimed to review neonatal sepsis caused by multi-drug resistant Enterobacteriaceae (MDRE) in neonates in Johannesburg, South Africa.</p></sec><sec id="ASec3"><title>Methods</title><p id="Par3">This was a cross sectional retrospective review of MDRE in neonates admitted to a tertiary neonatal unit between 1 January 2013 and 31 December 2015.</p></sec><sec id="ASec4"><title>Results</title><p id="Par4">There were 465 infections in 291 neonates. 68.6% were very low birth weight (&lt; 1500 g). The median age of infection was 14.0 days. Risk factors for MDRE included prematurity (<italic>p</italic> = 0.01), lower birth weight (<italic>p</italic> = 0.04), maternal HIV infection (<italic>p</italic> = 0.02) and oxygen on day 28 (<italic>p</italic> &lt; 0.001). The most common isolate was <italic>Klebsiella pneumoniae</italic> (66.2%). Total MDRE isolates increased from 0.39 per 1000 neonatal admissions in 2013 to 1.4 per 1000 neonatal admissions in 2015 (<italic>p</italic> &lt; 0.001). There was an increase in carbapenem-resistant Enterobacteriaceae (CRE) from 2.6% in 2013 to 8.9% in 2015 (<italic>p</italic> = 0.06). Most of the CRE were New Delhi metallo—β lactamase- (NDM) producers.</p><p id="Par5">The all-cause mortality rate was 33.3%. Birth weight (<italic>p</italic> = 0.003), necrotising enterocolitis (<italic>p</italic> &lt; 0.001) and mechanical ventilation (<italic>p</italic> = 0.007) were significantly associated with mortality. <italic>Serratia marcescens</italic> was isolated in 55.2% of neonates that died.</p></sec><sec id="ASec5"><title>Conclusions</title><p id="Par6">There was a significant increase in MDRE in neonatal sepsis during the study period, with the emergence of CRE. This confirms the urgent need to intensify antimicrobial stewardship efforts and address infection control and prevention in neonatal units in LMICs. Overuse of broad- spectrum antibiotics should be prevented.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Neonatal Sepsis</kwd><kwd>Enterobacteriaceae</kwd><kwd>Carbapenem-resistant</kwd><kwd><italic>Klebsiella pneumoniae</italic></kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>9</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12887_2019_Article_1709.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Pediatrics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Internal Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">Sepsis remains a major cause of morbidity and mortality in preterm infants [<xref ref-type="bibr" rid="CR1">1</xref>]. There has been a significant increase in neonatal sepsis caused by multi-drug resistant organisms (MDRO) in the past decade [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. More than half the organisms causing bloodstream infections (BSI) in a neonatal unit in Johannesburg, South Africa were due to MDRO [<xref ref-type="bibr" rid="CR3">3</xref>]. In a recent report from Jordan, two thirds of organisms causing neonatal sepsis were MDRO and most of the gram-negative organisms were extended-spectrum beta-lactamase (ESBL) producers [<xref ref-type="bibr" rid="CR1">1</xref>]. Many preterm infants are colonised with MDRO - more than half the <italic>Klebsiella pneumoniae</italic> and <italic>Escherichia coli</italic> isolated from a group of preterm infants in Malaysia were MDRO [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par20">Infections with multi-drug resistant gram-negative organisms, especially Enterobacteriaceae, are of concern in preterm infants. Neonatal sepsis caused by these pathogens is increasing and there are limited choices available for treatment [<xref ref-type="bibr" rid="CR5">5</xref>]. Infections with multi-drug resistant Enterobacteriaceae (MRDE) are associated with poor outcome and high case fatality rates, especially in low and middle income countries (LMIC) [<xref ref-type="bibr" rid="CR5">5</xref>]. Mechanisms of antibiotic resistance in Enterobacteriaceae include production of ESBLs or carbapenemases [<xref ref-type="bibr" rid="CR5">5</xref>]. There are recent reports of colistin-resistant Enterobacteriaceae in neonates [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par21">Carbapenem-resistant organisms were already described as a cause of neonatal septicaemia in India in 2007 [<xref ref-type="bibr" rid="CR6">6</xref>]. It is not clear whether patterns of ESBL and carbapenem-resistant Enterobacteriaceae (CRE) reflect national resistance patterns or are specific to the neonatal units. The predominant CRE strain in Asia and the West Pacific is New Delhi metallo-beta-lactamase (NDM − 1), whereas that in Europe and the USA is <italic>Klebsiella pneumoniae</italic> carbapenemase (KPC) [<xref ref-type="bibr" rid="CR5">5</xref>]. There is limited information on CRE in Africa. There is a report from Morocco where the predominant strain was OXA β-lactamase, i.e. OXA-48 carbapenemase [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par22">{Magiorakos, 2012 #2052} NDM and KPC (KPC-2) were first described in adult patients in Johannesburg in 2011 [<xref ref-type="bibr" rid="CR8">8</xref>]. The aim of this study is to describe the patterns of MDRE, including CRE, in a neonatal unit in Johannesburg, South Africa.</p></sec><sec id="Sec2" sec-type="methods"><title>Subjects and methods</title><p id="Par23">This is a retrospective descriptive cross-sectional study. All newborn neonates admitted to the neonatal unit between 01 January 2013 and 31 December 2015 were eligible for inclusion. The study group included all neonates with culture proven blood stream infection (BSI) caused by MDRE. A control group of 30% of all neonates without infection admitted to the neonatal unit during the study period was randomly generated from the neonatal database using SPSS IBM 24. Subjects were identified through the laboratory information system of the National Health Laboratory Service (NHLS). Patient characteristics were obtained from the neonatal computer database. Information was obtained from hospital records on discharge of each neonatal patient and was entered into a computerised database for the purpose of quality control. Data was managed using Research Electronic Data Capture (REDCAP), hosted by the University of the Witwatersrand [<xref ref-type="bibr" rid="CR9">9</xref>]. Maternal information, demographic and clinical characteristics, as well as survival to hospital discharge, were described for each patient. Causative organisms and their antimicrobial sensitivity patterns were described. Organism identification and antimicrobial susceptibility testing was done on the Vitek 2® (bioMerieux, Marcy-I’Etoile, France). Vitek 2 breakpoint interpretation was based on the Clinical and Laboratory Standards Institute (CLSI) guidelines. Isolates were characterised as CRE based on carbapenem Etest® (bioMerieux, Marcy-I’Etoile, France) minimum inhibitory concentration (MIC) testing. Colistin broth micro-dilution testing was not performed and hence colistin susceptibility rates cannot be reported for all isolates. Multiplex PCR for the carbapenemase genes (for <italic>bla</italic>NDM, <italic>bla</italic>KPC, <italic>bla</italic>OXA-48 and its variants, <italic>bla</italic>GES, <italic>bla</italic>IMP and <italic>bla</italic>VIM; LightMix Modular kits, Roche Diagnostics, Basel, Switzerland) was performed on a subset of the CRE isolates. Typing of isolates was not performed.</p><sec id="Sec3"><title>Statistical analysis</title><p id="Par24">IBM SPSS 24 was used to analyse the data.. Maternal and neonatal characteristics were described for each patient (not bacterial isolate). Microbiological information (resistance patterns, isolates over time) was analysed for each bacterial isolate. Mean and standard deviation or median and range, were used to describe central tendency in continuous variables, depending on the distribution of the data. Categorical variables were described using frequency and percentages. Only valid cases were analysed for each variable (i.e. missing cases were excluded). Two comparisons were performed. Firstly, survivors and non- survivors within the MDRE group were compared to determine risk factors for mortality. Secondly, the MDRE group and control group were compared to establish associations with MDRE infection. Frequencies were compared using Chi Square analysis, while unpaired t tests were used to compare continuous variables, as the data was normally distributed. A <italic>p</italic> value of 0.05 was considered to be statistically significant. Adjusted odds ratios were determined through binary logistic regression for significant associations with mortality and MDRE infection respectively.</p></sec><sec id="Sec4"><title>Ethics</title><p id="Par25">Ethics clearance was obtained from the Human Research Ethics Committee of the University of the Witwatersrand (Certificate M 151108). Permission was obtained to access the Laboratory information system from the NHLS.</p></sec><sec id="Sec5"><title>Definitions</title><p id="Par26">Early-onset sepsis (EOS) was defined as culture proven sepsis within the first 72 h of life, while late onset sepsis (LOS) was referred to as culture proven sepsis after 72 h of life [<xref ref-type="bibr" rid="CR1">1</xref>]. Multidrug resistance was defined as the isolate being non-susceptible to ≥1 agent in ≥3 antimicrobial categories [<xref ref-type="bibr" rid="CR10">10</xref>]. The presence of resistance to third generation cephalosporins was used as a marker for ESBL production. The presence of cefoxitin resistance was used as a marker for Amp C beta-lactamase production. Necrotising enterocolitis (NEC) was defined as modified Bell’s stages 2 or 3 [<xref ref-type="bibr" rid="CR11">11</xref>]. Resuscitation at birth was defined as the need for bag mask ventilation. “Outborn” referred to all neonates born outside the study hospital. Very low birth weight indicated neonates with a birth weight below 1500 g. Mortality was defined as all-cause mortality during hospitalization.</p></sec></sec><sec id="Sec6" sec-type="results"><title>Results</title><sec id="Sec7"><title>Characteristics associated with MDRE sepsis</title><p id="Par27">There were a total of 465 MDRE infections in 291 neonates and 2146 control neonates without infection. The comparison between neonates with MDRE and controls is shown in Table <xref rid="Tab1" ref-type="table">1</xref>. Control neonates weighed significantly more at birth than those neonates with MDRE sepsis 1878 g (SD 956) vs 1438 g (SD 660) (<italic>p</italic> &lt; 0.001). Neonates with MDRE sepsis were significantly more preterm than controls − 30.4 weeks (SD 4.0) vs 32.9 weeks (SD 4.8) (p &lt; 0.001) The all-cause mortality rate was higher in MDRE neonates than controls − 97/291 (33.3%) vs- 49/2146 (2.2%)) (<italic>p</italic> &lt; 0.001). Most of the neonates with MDRE sepsis (199/291; 68.6%) were very low birth weight. The median age at presentation with MDRE was 14.0 days (IQR 20). Although more than one third of neonates with MDRE sepsis were HIV exposed, there was only one neonate (1/108; 0.9%) with a positive HIV polymerase chain reaction at birth. Adjusted odds ratios for those variables significantly associated with MDRE are shown in Table <xref rid="Tab2" ref-type="table">2</xref>. Prematurity, lower birth weight, maternal HIV infection and oxygen on day 28 were all associated with MDRE infection.
<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Characteristics associated with multi-drug resistant Enterobacteriaceae infection in neonates</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Variable</p></th><th><p>Babies with MDRE sepsis n/N (%)</p></th><th><p>Babies without sepsis n/N (%)</p></th><th><p><italic>p</italic> value</p></th></tr></thead><tbody><tr><td><p>Inborn</p></td><td><p>196/288 (68.1)</p></td><td><p>1716/2096 (81.9)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Attended antenatal care</p></td><td><p>188/254 (74.0)</p></td><td><p>1663/1971 (84.4)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Maternal chorioamnionitis</p></td><td><p>7/238 (2.9)</p></td><td><p>47/1875 (2.5)</p></td><td><p>0.689</p></td></tr><tr><td><p>Maternal HIV</p></td><td><p>108/279 (38.7)</p></td><td><p>600/2009 (29.9)</p></td><td><p>0.003</p></td></tr><tr><td><p>Vaginal Delivery</p></td><td><p>134/261 (51.3)</p></td><td><p>902/2076 (43.4)</p></td><td><p>0.016</p></td></tr><tr><td><p>Male</p></td><td><p>157/291 (54.0)</p></td><td><p>1113/2135 (52.1)</p></td><td><p>0.697</p></td></tr><tr><td><p>Multiple gestation</p></td><td><p>44/284 (15.5)</p></td><td><p>267/2078 (12.8)</p></td><td><p>0.216</p></td></tr><tr><td><p>Resuscitation at birth</p></td><td><p>112/269 (41.6)</p></td><td><p>451/2086 (21.6)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Oxygen on day 28</p></td><td><p>118/262 (45.0)</p></td><td><p>161/1957 (8.2)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Nasal CPAP</p></td><td><p>168/191 (87.9)</p></td><td><p>961/2146 (44.8)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Mechanical ventilation</p></td><td><p>85/196 (43.4)</p></td><td><p>791/2101 (37.6)</p></td><td><p>0.115</p></td></tr><tr><td><p>Necrotising enterocolitis (Grade 2 and 3)</p></td><td><p>61/288 (21.2)</p></td><td><p>164/2080 (7.9)</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Surgery (excluding necrotising enterocolitis)`</p></td><td><p>45/284 (15.8)</p></td><td><p>71/2065 (3.4)</p></td><td><p>&lt; 0.001</p></td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Adjusted odds ratios for characteristics associated with multi-drug resistant Enterobacteriaceae infection in neonates</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Characteristic</p></th><th><p>Odds ratio</p></th><th><p>95% confidence interval</p></th><th><p><italic>P</italic> value</p></th></tr></thead><tbody><tr><td><p>Maternal HIV</p></td><td><p>1.60</p></td><td><p>1.076–2.303</p></td><td><p>0.02</p></td></tr><tr><td><p>Oxygen on day 28</p></td><td><p>5.855</p></td><td><p>3.976–8.621</p></td><td><p>&lt; 0.001</p></td></tr><tr><td><p>Birth weight</p></td><td><p>0.998</p></td><td><p>0.997–0.999</p></td><td><p>0.01</p></td></tr><tr><td><p>Gestational age</p></td><td><p>0.881</p></td><td><p>0.794–0.977</p></td><td><p>0.04</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Bacterial isolates</title><p id="Par28">There were 41/465 (8.8%) of EOS caused by MDRE. Most neonates (195/291; 67%) had a single episode of infection, 18.2% (53/291) had two episodes of infection and 14.8% (43/291) had three or more episodes. The most common isolate was <italic>Klebsiella pneumoniae</italic> (308/465; 66.2%), followed by <italic>Enterobacter cloacae</italic>. (49/465; 10.5%), <italic>Escherichia coli</italic> (45/465; 9.6%); <italic>Serratia marcescens</italic> (29/465; 6.2%), <italic>Klebsiella</italic> spp. (<italic>Klebsiella</italic> spp. other than <italic>K. pneumoniae</italic>) (27/465; 5.8%), <italic>Proteus mirabilis</italic> (3/465, 0.65%), <italic>Citrobacter freundii</italic> (2/465, 0.43%), <italic>Citrobacter koseri</italic> (1/465, 1.2%) and <italic>Salmonella</italic> spp. (1/465, 1.2%).</p><p id="Par29">Resistance patterns of all isolates are shown in Table <xref rid="Tab3" ref-type="table">3</xref>. High rates of resistance to ampicillin and amoxicillin -clavulanic acid were observed across most of the Enterobacteriaceae. Seventy-one percent (330/463) and 23% (107/456) of all MDRE isolates were ESBL- and Amp C β-lactamase-producers, respectively. Of the 29% of MDRE isolates that were not ESBL producers, 40% (53/133) were Amp C-producers. Non-ESBL, non-Amp C-producing isolates (80/133) remained susceptible to cefepime. Eighty-two percent (369/452) of MDRE isolates retained susceptibility to ciprofloxacin. Both imipenem (426/448) and meropenem (439/461), showed a high susceptibility rate of 95%. Amikacin displayed a slightly higher susceptibility rate at 96% (433/448).
<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Antimicrobial resistance patterns in different isolates (%)</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Antimicrobial agent</p></th><th><p><italic>K.Pneumonia</italic></p></th><th><p>Klebsiella sp.</p></th><th><p><italic>Enterobacter</italic></p></th><th><p><italic>E.Coli</italic></p></th><th><p><italic>Serattia</italic></p></th><th><p>Other</p></th></tr></thead><tbody><tr><td><p>Ampicillin/Amoxil</p></td><td><p>98,7</p></td><td><p>100</p></td><td><p>85,7</p></td><td><p>84,4</p></td><td><p>84,2</p></td><td><p>100</p></td></tr><tr><td><p>Amox-Clavulanate</p></td><td><p>75,9</p></td><td><p>55,5</p></td><td><p>95,9</p></td><td><p>26,6</p></td><td><p>100</p></td><td><p>14,2</p></td></tr><tr><td><p>Piperacillin-tazobactam</p></td><td><p>39,4</p></td><td><p>25,9</p></td><td><p>22,4</p></td><td><p>6,6</p></td><td><p>14,2</p></td><td><p>14,2</p></td></tr><tr><td><p>Cefotaxime</p></td><td><p>89,8</p></td><td><p>62,9</p></td><td><p>31,9</p></td><td><p>20</p></td><td><p>27,5</p></td><td><p>14,2</p></td></tr><tr><td><p>Ceftazidime</p></td><td><p>90,5</p></td><td><p>59,5</p></td><td><p>28,5</p></td><td><p>20</p></td><td><p>27,5</p></td><td><p>14,2</p></td></tr><tr><td><p>Cefepime</p></td><td><p>89,2</p></td><td><p>53,8</p></td><td><p>12,2</p></td><td><p>17,7</p></td><td><p>24,1</p></td><td><p>0</p></td></tr><tr><td><p>Ciprofloxacillin</p></td><td><p>22,9</p></td><td><p>18,5</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Ertapenem</p></td><td><p>4,3</p></td><td><p>0</p></td><td><p>2,1</p></td><td><p>0</p></td><td><p>0</p></td><td><p>28</p></td></tr><tr><td><p>Imipenem</p></td><td><p>6,1</p></td><td><p>3,7</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>28,5</p></td></tr><tr><td><p>Meropenem</p></td><td><p>6,5</p></td><td><p>3,8</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>14,2</p></td></tr><tr><td><p>Amikacin</p></td><td><p>4,9</p></td><td><p>5</p></td><td><p>0</p></td><td><p>2,2</p></td><td><p>0</p></td><td><p>25</p></td></tr><tr><td><p>Tobramycin</p></td><td><p>66,6</p></td><td><p>50</p></td><td><p>4</p></td><td><p>25,9</p></td><td><p>25</p></td><td><p>30</p></td></tr></tbody></table></table-wrap></p><p id="Par30">The variation in annual MDRE isolates is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Total MDRE isolates increased from 0.39 per 1000 neonatal admissions in 2013 to 1.4 per 1000 neonatal admissions in 2015 (<italic>p</italic> &lt; 0.001). Monthly variation in isolates of <italic>K. pneumoniae</italic>, <italic>E. cloacae, S. marcescens</italic> and <italic>E. coli</italic> is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.
<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Multi drug resistant bacterial isolates by year</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12887_2019_1709_Fig1_HTML.png" id="MO1"/></p></fig><fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Multi-drug resistant Enterobacteriaceae bacterial isolates by month</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12887_2019_1709_Fig2_HTML.png" id="MO2"/></p></fig></p></sec><sec id="Sec9"><title>Carbapenem resistant isolates</title><p id="Par31">There were 26 CREs isolated from 24 neonates shown in Table <xref rid="Tab4" ref-type="table">4</xref>. There was one isolate each of <italic>C. freundii</italic> and <italic>Klebsiella oxytoca</italic> and two <italic>E. cloacae</italic>. The remaining 22 isolates were <italic>K. pneumoniae</italic>. CRE isolates per year are shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. There was an increase in CRE from 2.6% in 2013 to 8.9% in 2015 (<italic>p</italic> = 0.06). One <italic>Klebsiella pneumoniae</italic> isolate produced Verona Integron-Mediated Metallo-β-lactamase (VIM) and fourteen produced NDM. The <italic>K. oxytoca</italic> produced VIM and the <italic>C. freundii</italic> produced NDM. One isolate was negative for CPE genes and 8 isolates were not tested. Ninety-two percent (24/26) and 62% (16/26) of the CRE isolates were ciprofloxacin and amikacin susceptible, respectively.
<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Carbapenem resistant Enterobacteriaceae determinants and susceptibility profiles</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Number</p></th><th rowspan="2"><p>Organism</p></th><th rowspan="2"><p>Carbapenemase Gene</p></th><th colspan="5"><p>Antibiotic Susceptibility</p></th></tr><tr><th><p>Amikacin</p></th><th><p>Ciprofloxacin</p></th><th><p>Ertapenem</p></th><th><p>Meropenem</p></th><th><p>Imipenem</p></th></tr></thead><tbody><tr><td><p>1.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>*NT</p></td><td><p>**R</p></td><td><p>***S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td></tr><tr><td><p>2.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NT</p></td><td><p>****I</p></td><td><p>S</p></td><td><p>R</p></td><td><p>I</p></td><td><p>S</p></td></tr><tr><td><p>3.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>4.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>5.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>6.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>7.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>VIM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>8.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>9.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>10.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>11.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>12.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>13.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>14.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>15.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>16.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>17.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>18.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>19.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NDM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>20.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>21.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NEG</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>22.</p></td><td><p><italic>K. pneumoniae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>I</p></td></tr><tr><td><p>23.</p></td><td><p><italic>K. oxytoca</italic></p></td><td><p>VIM</p></td><td><p>S</p></td><td><p>S</p></td><td><p>NT</p></td><td><p>R</p></td><td><p>R</p></td></tr><tr><td><p>24.</p></td><td><p><italic>E. cloacae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td></tr><tr><td><p>25.</p></td><td><p><italic>E. cloacae</italic></p></td><td><p>NT</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td></tr><tr><td><p>26.</p></td><td><p><italic>C. freundii</italic></p></td><td><p>NDM</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td></tr></tbody></table><table-wrap-foot><p>NT- not tested</p><p>**R- resistant</p><p>***S- susceptible</p><p>****I- intermediately-susceptible</p><p>The susceptibility to Amikacin and/or Ciprofloxacin allows these antibiotics to be considered as treatment options either as (1) monotherapy or (2) in combination with each other or (3) in combination with a carbapenem, which spares colistin use</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Carbapenem resistance by year</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12887_2019_1709_Fig3_HTML.png" id="MO3"/></p></fig></p></sec><sec id="Sec10"><title>Mortality in the MDRE neonates</title><p id="Par32">All-cause mortality in the neonates with MDRE sepsis was 33.3% (97/291). Adjusted odds ratios for variables significantly associated with mortality were birth weight (OR 0.997; 95%CI 0.996–0.999, <italic>p</italic> = 0.003), NEC (OR 4.644; 95%CI 2.012–1-.715, <italic>p</italic> &lt; 0.001) and mechanical ventilation (2.496; 95%CI 1.282–4.860, <italic>p</italic> = 0.007). Mortality rate by isolate is shown in Table <xref rid="Tab5" ref-type="table">5</xref>. The highest mortality rate was seen in neonates with <italic>S. marcescens</italic> BSI (55.2%) (<italic>p</italic> &lt; 0.017). Neither ESBL production nor carbapenem resistance was significantly associated with mortality.
<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>Mortality by bacterial isolate</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Bacteria</p></th><th><p>Total</p></th><th><p>Died</p></th><th><p>% Mortality</p></th></tr></thead><tbody><tr><td><p><italic>Enterobacter cloacae</italic></p></td><td><p>46</p></td><td><p>20</p></td><td><p>43.5</p></td></tr><tr><td><p><italic>Escherichia coli</italic></p></td><td><p>42</p></td><td><p>17</p></td><td><p>40.5</p></td></tr><tr><td><p><italic>Klebsiella pneumoniae</italic></p></td><td><p>306</p></td><td><p>89</p></td><td><p>29.1</p></td></tr><tr><td><p><italic>Klebsiella spp</italic></p></td><td><p>25</p></td><td><p>5</p></td><td><p>20.0</p></td></tr><tr><td><p><italic>Serratia marcescens</italic></p></td><td><p>29</p></td><td><p>16</p></td><td><p>55.2</p></td></tr><tr><td><p>Other</p></td><td><p>6</p></td><td><p>2</p></td><td><p>33.0</p></td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par33">This is the first report on the increase in MDRE, in particular CRE, in neonates in South Africa. The most common isolate was <italic>K. pneumoniae.</italic> These results are in keeping with other reports from LMICs where <italic>Klebsiella</italic> spp. have also been the predominant pathogen causing neonatal sepsis [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The Study for Monitoring Antimicrobial resistance (SMART), which studied bacterial resistance patterns globally between 2002 to 2011 from isolates in urinary tract infections and intra-abdominal sepsis, reported an increase in ESBLs in all continents except Africa [<xref ref-type="bibr" rid="CR14">14</xref>]. Unfortunately, this is no longer the case - ESBL isolates are not uncommon in Africa. A report form Burkina Faso found that almost 60% of Enterobacteriaceae were ESBL producers, [<xref ref-type="bibr" rid="CR15">15</xref>]. while more than half of all <italic>Klebsiella i</italic>solates in South Africa were reported to produce ESBLs [<xref ref-type="bibr" rid="CR16">16</xref>]</p><p id="Par34">In the present study, there was a marked increase in all MDRE over the study period, but particularly in isolates of <italic>Klebsiella</italic> spp., which more than doubled. This increase in MDRE in neonates is in keeping with global trends [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Carbapenem-resistant <italic>K. pneumoniae</italic> was first reported in 2008 in neonates in Karachi, Pakistan [<xref ref-type="bibr" rid="CR2">2</xref>]. and by 2011, 72% of <italic>K. pneumoniae</italic> isolates were resistant to carbapenems. The first case of carbapenem-resistant <italic>K. pneumoniae</italic> in a neonate in South Africa was described in 2015 in KwaZulu Natal [<xref ref-type="bibr" rid="CR17">17</xref>], while invasive CRE was isolated in paediatric patients in Cape Town in 2012 [<xref ref-type="bibr" rid="CR18">18</xref>]. Neonatal CRE was first noted in the present study in 2013 and by 2015, 7.3% of the MDRE isolates were carbapenem resistant.</p><p id="Par35">Factors associated with MDRE sepsis in the present study included prematurity, oxygen on day 28 of life and lower birth weight. This is in agreement with other reports where prematurity, low birth weight, prolonged hospitalization, surgical procedures, mechanical ventilation and use of invasive devices were reported as risk factors for MDRE [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>]. However, the risk factors for all late onset neonatal sepsis include lower birth weight and gestational age, necrotising enterocolitis and bronchopulmonary dysplasia [<xref ref-type="bibr" rid="CR23">23</xref>]. In order to determine risk factors that are specific for MDRE infection, a control group of neonates with late onset sepsis without MDRE organisms should be used, rather than neonates without sepsis. The case fatality rate in the current study was 33.3% which is slightly higher than that reported from a review of MDRE in Taiwan [<xref ref-type="bibr" rid="CR24">24</xref>]. Mortality in the present study was significantly associated with lower birth weight, NEC and mechanical ventilation.</p><p id="Par36">Most of the MDRE isolates in the current study were resistant to the penicillins and cephalosporins; the most common mechanism of resistance being production of ESBLs, particularly in <italic>Klebsiella</italic> spp. The frequency of ESBL producers in the current study resulted in widespread use of carbapenems (usually meropenem) for empiric treatment of presumed sepsis in neonates. This compounds the problem of resistant organisms as widespread use of broad-spectrum antibiotics is an important mechanism in the development and spread of MDRE [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Previous exposure to carbapenems is a risk factor for subsequent CRE [<xref ref-type="bibr" rid="CR18">18</xref>]. Treatment options for confirmed MDRE sepsis were also limited. Fluoroquinolones and aminoglycosides were not frequently used, due to significant side effects. Cefepime remains a treatment option for the isolates that were non-ESBL and non-Amp C producers. Meropenem was the appropriate antibiotic choice in the majority of isolates. Several of the CRE isolates were susceptible to Amikacin and/or Ciprofloxacin. As a result, these antibiotics could be considered as treatment options either as (1) monotherapy or (2) in combination with each other or (3) in combination with a carbapenem. This would result in sparing Colistin use. The emergence of colistin resistance in neonatal sepsis has been reported in other studies [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The lack of appropriate colistin susceptibility testing precludes the determination of the presence colistin resistance in this study. Previous reports have suggested a seasonal incidence in <italic>Klebsiella</italic> infections in neonates [<xref ref-type="bibr" rid="CR2">2</xref>]. Although there was marked variation in the number of MDRE isolate (including <italic>Klebsiella</italic> spp.<italic>)</italic> in the current study, there was no evidence of a seasonal variation.</p><p id="Par37">The mortality rate was highest in neonates infected with <italic>S. marcescens</italic> in the present study. <italic>S. marcescens</italic> is an important nosocomial pathogen, especially in neonatal intensive care units (NICU) where several outbreaks have been described globally. It causes serious infections, including bacteremia, pneumonia<bold>,</bold> urinary tract infections and meningitis with significant morbidity and mortality rates among newborns. Risk factors for acquisition of nosocomial infections caused by <italic>S. marcescens</italic> in NICUs are low birth weight, long duration of hospitalization and receiving of critical care [<xref ref-type="bibr" rid="CR26">26</xref>]. Although we found a higher mortality rate in <italic>S. marcescens</italic> infections, we did not analyze possibly confounding variables such as the severity of illness related to prematurity in these infants.</p><p id="Par38">Prevention of MDRE infections includes screening for colonization, antibiotic stewardship, and stringent infection control practices including, hand hygiene practices, use of appropriate personal protective equipment, and decreased use of invasive devices [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The importance of the neonatal gut microbiome has been underestimated. A recently published systematic review showed that supplementation with probiotics reduced the incidence of LOS in preterm infants [<xref ref-type="bibr" rid="CR27">27</xref>]. Many neonates colonized with MDRE develop infection with the same organism and the presence of components of the gut normal flora, such as <italic>Lactobacillus plantarum</italic> and <italic>Bifidobacterium breve,</italic> can have a protective effect by exhibiting antimicrobial activity against gut pathogens [<xref ref-type="bibr" rid="CR25">25</xref>]</p><sec id="Sec12"><title>Limitations of the study</title><p id="Par39">This was a retrospective review of an existing database, so timing of complications and antibiotic therapy for BSI could not be evaluated. In addition, many possible risk factors for sepsis, such as catheterization, time to the onset of feeding, and total parenteral nutrition had not been captured and were therefore not available for analysis.</p></sec></sec><sec id="Sec13" sec-type="conclusions"><title>Conclusions</title><p id="Par40">The present study confirms that there is an alarming increase in MDRE with the emergence of CRE. This confirms the urgent need to intensify antimicrobial stewardship efforts and address infection control and prevention in neonatal units in LMICs. In particular, the overuse of broad-spectrum antibiotics should be discouraged. In addition, other treatment and prevention modalities, such as strategies targeting the neonatal gut microbiome, should be investigated.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors gratefully acknowledge that assistance of Ms. Melanie Mcree in collecting data for the study.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>DEB – conceptualized the paper, obtained ethics clearance, analyzed data, wrote drafts and submitted the manuscript. RB- data collection and analysis, revision of various drafts. TN, NB, TT – data collection and analysis, revision of various drafts. VAD, PAC, MM and JL – reviewed and advised on study design and methodology, revision of various drafts. All authors reviewed and approved the final submission.</p></sec><sec><title>Funding</title><p>None to declare.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>Data will be made available upon reasonable request to the corresponding author.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par41">The study was approved by the Human Research Ethics Committee of the University of the Witwatersrand (Clearance Number M 15 1108). This was a retrospective record review of de-identified data so consent to participate was not required.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par42">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par43">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Yusef D, Shalakhti T, Awad S, Algharaibeh H, Khasawneh W. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review. Pediatr Neonatol. 2017.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleem</surname><given-names>AF</given-names></name><name><surname>Qamar</surname><given-names>FN</given-names></name><name><surname>Shahzad</surname><given-names>H</given-names></name><name><surname>Qadir</surname><given-names>M</given-names></name><name><surname>Zaidi</surname><given-names>AK</given-names></name></person-group><article-title xml:lang="en">Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan</article-title><source>Int J Infect Dis</source><year>2013</year><volume>17</volume><issue>11</issue><fpage>e961</fpage><lpage>e965</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXptFCltLw%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ijid.2013.04.007</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballot</surname><given-names>DE</given-names></name><name><surname>Nana</surname><given-names>T</given-names></name><name><surname>Sriruttan</surname><given-names>C</given-names></name><name><surname>Cooper</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">Bacterial bloodstream infections in neonates in a developing country</article-title><source>ISRN pediatrics</source><year>2012</year><volume>2012</volume><fpage>508512</fpage><pub-id pub-id-type="doi">10.5402/2012/508512</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>PS</given-names></name><name><surname>Ahmad Kamar</surname><given-names>A</given-names></name><name><surname>Chong</surname><given-names>CW</given-names></name><name><surname>Yap</surname><given-names>IK</given-names></name><name><surname>Thong</surname><given-names>KL</given-names></name><name><surname>Choo</surname><given-names>YM</given-names></name><name><surname>Md Yusof</surname><given-names>MY</given-names></name><name><surname>Teh</surname><given-names>CS</given-names></name></person-group><article-title xml:lang="en">Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU)</article-title><source>Pathogens Global health</source><year>2016</year><volume>110</volume><issue>6</issue><fpage>238</fpage><lpage>246</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsFyrur%2FJ</pub-id><pub-id pub-id-type="doi">10.1080/20477724.2016.1229884</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folgori</surname><given-names>L</given-names></name><name><surname>Bielicki</surname><given-names>J</given-names></name><name><surname>Heath</surname><given-names>PT</given-names></name><name><surname>Sharland</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Antimicrobial-resistant gram-negative infections in neonates: burden of disease and challenges in treatment</article-title><source>Curr Opin Infect Dis</source><year>2017</year><volume>30</volume><issue>3</issue><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000371</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Sen</surname><given-names>B</given-names></name><name><surname>Pal</surname><given-names>T</given-names></name><name><surname>Som</surname><given-names>T</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>11</issue><fpage>e112101</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0112101</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barguigua</surname><given-names>A</given-names></name><name><surname>El Otmani</surname><given-names>F</given-names></name><name><surname>Talmi</surname><given-names>M</given-names></name><name><surname>Zerouali</surname><given-names>K</given-names></name><name><surname>Timinouni</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community</article-title><source>Diagn Microbiol Infect Dis</source><year>2012</year><volume>73</volume><issue>3</issue><fpage>290</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2012.03.011</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brink</surname><given-names>AJ</given-names></name><name><surname>Coetzee</surname><given-names>J</given-names></name><name><surname>Clay</surname><given-names>CG</given-names></name><name><surname>Sithole</surname><given-names>S</given-names></name><name><surname>Richards</surname><given-names>GA</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa</article-title><source>J Clin Microbiol</source><year>2012</year><volume>50</volume><issue>2</issue><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XktVKhu7w%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.05956-11</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>PA</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><name><surname>Thielke</surname><given-names>R</given-names></name><name><surname>Payne</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>N</given-names></name><name><surname>Conde</surname><given-names>JG</given-names></name></person-group><article-title xml:lang="en">Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support</article-title><source>J Biomed Inform</source><year>2009</year><volume>42</volume><issue>2</issue><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magiorakos</surname><given-names>AP</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Carey</surname><given-names>RB</given-names></name><name><surname>Carmeli</surname><given-names>Y</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Giske</surname><given-names>CG</given-names></name><name><surname>Harbarth</surname><given-names>S</given-names></name><name><surname>Hindler</surname><given-names>JF</given-names></name><name><surname>Kahlmeter</surname><given-names>G</given-names></name><name><surname>Olsson-Liljequist</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><issue>3</issue><fpage>268</fpage><lpage>281</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XmvValtb4%3D</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>MJ</given-names></name><name><surname>Ternberg</surname><given-names>JL</given-names></name><name><surname>Feigin</surname><given-names>RD</given-names></name><name><surname>Keating</surname><given-names>JP</given-names></name><name><surname>Marshall</surname><given-names>R</given-names></name><name><surname>Barton</surname><given-names>L</given-names></name><name><surname>Brotherton</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging</article-title><source>Ann Surg</source><year>1978</year><volume>187</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="coi">1:STN:280:DyaE1c%2FnvFCntQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1097/00000658-197801000-00001</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dramowski</surname><given-names>A</given-names></name><name><surname>Madide</surname><given-names>A</given-names></name><name><surname>Bekker</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Neonatal nosocomial bloodstream infections at a referral hospital in a middle-income country: burden, pathogens, antimicrobial resistance and mortality</article-title><source>Paediatrics Int Child Health</source><year>2015</year><volume>35</volume><issue>3</issue><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1179/2046905515Y.0000000029</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zea-Vera</surname><given-names>A</given-names></name><name><surname>Ochoa</surname><given-names>TJ</given-names></name></person-group><article-title xml:lang="en">Challenges in the diagnosis and management of neonatal sepsis</article-title><source>J Trop Pediatr</source><year>2015</year><volume>61</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/tropej/fmu079</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrissey</surname><given-names>I</given-names></name><name><surname>Hackel</surname><given-names>M</given-names></name><name><surname>Badal</surname><given-names>R</given-names></name><name><surname>Bouchillon</surname><given-names>S</given-names></name><name><surname>Hawser</surname><given-names>S</given-names></name><name><surname>Biedenbach</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to</article-title><source>Pharmaceuticals (Basel, Switzerland) 2013</source><year>2011</year><volume>6</volume><issue>11</issue><fpage>1335</fpage><lpage>1346</lpage></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouedraogo</surname><given-names>AS</given-names></name><name><surname>Sanou</surname><given-names>M</given-names></name><name><surname>Kissou</surname><given-names>A</given-names></name><name><surname>Sanou</surname><given-names>S</given-names></name><name><surname>Solare</surname><given-names>H</given-names></name><name><surname>Kabore</surname><given-names>F</given-names></name><name><surname>Poda</surname><given-names>A</given-names></name><name><surname>Aberkane</surname><given-names>S</given-names></name><name><surname>Bouzinbi</surname><given-names>N</given-names></name><name><surname>Sano</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">High prevalence of extended-spectrum ss-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso</article-title><source>BMC Infect Dis</source><year>2016</year><volume>16</volume><fpage>326</fpage><pub-id pub-id-type="doi">10.1186/s12879-016-1655-3</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasaikar</surname><given-names>S</given-names></name><name><surname>Obi</surname><given-names>L</given-names></name><name><surname>Morobe</surname><given-names>I</given-names></name><name><surname>Bisi-Johnson</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Molecular characteristics and antibiotic resistance profiles of Klebsiella isolates in Mthatha, eastern Cape Province, South Africa</article-title><source>Int J Microbiol</source><year>2017</year><volume>2017</volume><fpage>8486742</fpage><pub-id pub-id-type="doi">10.1155/2017/8486742</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhika Singh</surname><given-names>PM</given-names></name></person-group><article-title xml:lang="en">Koleka Mlisana, Kimesh Naidoo and Prashini Moodley: isolation of New Delhi Metallo-ßeta- Lactamase-1(NDM-1) producing Klebsiella pneumoniae in a neonate in Kwazulu-Natal, South Africa</article-title><source>J Paediatr Neonatal Care</source><year>2015</year><volume>2</volume><issue>4</issue><fpage>2</fpage></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malande</surname><given-names>OO</given-names></name><name><surname>Du Plessis</surname><given-names>A</given-names></name><name><surname>Rip</surname><given-names>D</given-names></name><name><surname>Bamford</surname><given-names>C</given-names></name><name><surname>Eley</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: a case series</article-title><source>S Afr Med J</source><year>2016</year><volume>106</volume><issue>9</issue><fpage>877</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.7196/SAMJ.2016.v106i9.11028</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pragosa</surname><given-names>H</given-names></name><name><surname>Marcal</surname><given-names>M</given-names></name><name><surname>Goncalves</surname><given-names>E</given-names></name><name><surname>Martins</surname><given-names>F</given-names></name><name><surname>Lopo-Tuna</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Multi-drug-resistant Enterobacteriaceae in a Portuguese neonatal intensive care unit</article-title><source>J Hospital Infect</source><year>2017</year><volume>96</volume><issue>2</issue><fpage>130</fpage><lpage>131</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC1crgt1Srsw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jhin.2017.03.015</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brink</surname><given-names>A</given-names></name><name><surname>Coetzee</surname><given-names>J</given-names></name><name><surname>Clay</surname><given-names>C</given-names></name><name><surname>Corcoran</surname><given-names>C</given-names></name><name><surname>van Greune</surname><given-names>J</given-names></name><name><surname>Deetlefs</surname><given-names>JD</given-names></name><name><surname>Nutt</surname><given-names>L</given-names></name><name><surname>Feldman</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>G</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention</article-title><source>S Afr Med J</source><year>2012</year><volume>102</volume><issue>7</issue><fpage>599</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.7196/SAMJ.5789</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukac</surname><given-names>PJ</given-names></name><name><surname>Bonomo</surname><given-names>RA</given-names></name><name><surname>Logan</surname><given-names>LK</given-names></name></person-group><article-title xml:lang="en">Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat</article-title><source>Clin Infect Dis</source><year>2015</year><volume>60</volume><issue>9</issue><fpage>1389</fpage><lpage>1397</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvFertLbN</pub-id><pub-id pub-id-type="pmid">25595742</pub-id><pub-id pub-id-type="pmcid">4415054</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akturk</surname><given-names>H</given-names></name><name><surname>Sutcu</surname><given-names>M</given-names></name><name><surname>Somer</surname><given-names>A</given-names></name><name><surname>Aydin</surname><given-names>D</given-names></name><name><surname>Cihan</surname><given-names>R</given-names></name><name><surname>Ozdemir</surname><given-names>A</given-names></name><name><surname>Coban</surname><given-names>A</given-names></name><name><surname>Ince</surname><given-names>Z</given-names></name><name><surname>Citak</surname><given-names>A</given-names></name><name><surname>Salman</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection</article-title><source>Braz J Infect Dis</source><year>2016</year><volume>20</volume><issue>2</issue><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.bjid.2015.12.004</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>BJ</given-names></name><name><surname>Hansen</surname><given-names>N</given-names></name><name><surname>Fanaroff</surname><given-names>AA</given-names></name><name><surname>Wright</surname><given-names>LL</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Ehrenkranz</surname><given-names>RA</given-names></name><name><surname>Lemons</surname><given-names>JA</given-names></name><name><surname>Donovan</surname><given-names>EF</given-names></name><name><surname>Stark</surname><given-names>AR</given-names></name><name><surname>Tyson</surname><given-names>JE</given-names></name><etal/></person-group><article-title xml:lang="en">Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network</article-title><source>Pediatrics</source><year>2002</year><volume>110</volume><issue>2 Pt 1</issue><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1542/peds.110.2.285</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MH</given-names></name><name><surname>Chu</surname><given-names>SM</given-names></name><name><surname>Hsu</surname><given-names>JF</given-names></name><name><surname>Lien</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>HR</given-names></name><name><surname>Chiang</surname><given-names>MC</given-names></name><name><surname>Fu</surname><given-names>RH</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name></person-group><article-title xml:lang="en">Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU</article-title><source>Pediatrics</source><year>2014</year><volume>133</volume><issue>2</issue><fpage>e322</fpage><lpage>e329</lpage><pub-id pub-id-type="doi">10.1542/peds.2013-1248</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delerue</surname><given-names>T</given-names></name><name><surname>De Pontual</surname><given-names>L</given-names></name><name><surname>Carbonnelle</surname><given-names>E</given-names></name><name><surname>Zahar</surname><given-names>JR</given-names></name></person-group><article-title xml:lang="en">The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population</article-title><source>F1000Research</source><year>2017</year><volume>6</volume><fpage>1217</fpage><pub-id pub-id-type="doi">10.12688/f1000research.10713.1</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chemsi</surname><given-names>M</given-names></name><name><surname>Hamid</surname><given-names>HHS</given-names></name><name><surname>Zerouali</surname><given-names>K</given-names></name><name><surname>Lehlimi</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">An outbreak of Serratia marcescens on the neonatal unit: description and investigations</article-title><source>J Infect Dis Ther</source><year>2016</year><volume>4</volume><fpage>306</fpage></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Aceti A, Maggio L, Beghetti I, Gori D, Barone G, Callegari ML, Fantini MP, Indrio F, Meneghin F, Morelli L, et al. Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis. Nutrients. 2017:9(8).</mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>BSI</term><def><p id="Par7">Blood stream infection</p></def></def-item><def-item><term>CRE</term><def><p id="Par8">Carbapenem resistant Enterobacteriaceae</p></def></def-item><def-item><term>EOS</term><def><p id="Par9">Early onset sepsis</p></def></def-item><def-item><term>ESBL</term><def><p id="Par10">Extended βlactamase</p></def></def-item><def-item><term>LMIC</term><def><p id="Par11">low and middle income country</p></def></def-item><def-item><term>LOS</term><def><p id="Par12">Late onset sepsis</p></def></def-item><def-item><term>MDRE</term><def><p id="Par13">Multi drug resistant Enterobacteriaceae</p></def></def-item><def-item><term>MDRO</term><def><p id="Par14">Multidrug resistant organisms</p></def></def-item><def-item><term>MIC</term><def><p id="Par15">Minimum inhibitory concentration</p></def></def-item><def-item><term>NDM 1</term><def><p id="Par16">New Delhi metallo β lactamase</p></def></def-item><def-item><term>NEC</term><def><p id="Par17">Necrotizing enterocolitis</p></def></def-item><def-item><term>REDCAP</term><def><p id="Par18">Research Electronic Data Capture</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Internal Medicine</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Pediatrics</facet-value></facet><facet name="keyword"><facet-value count="1">
                Klebsiella pneumoniae
              </facet-value><facet-value count="1">Carbapenem-resistant</facet-value><facet-value count="1">Enterobacteriaceae</facet-value><facet-value count="1">Neonatal Sepsis</facet-value></facet><facet name="pub"><facet-value count="1">BMC Pediatrics</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Australia</facet-value><facet-value count="1">South Africa</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
